ThermoGenesis (THMO) Revenue & Revenue Breakdown

Overview ForecastFinancials Chart

ThermoGenesis Revenue Highlights

Latest Revenue (Y)

$9.45M

Latest Revenue (Q)

$2.74M

Main Segment (Y)

Device Revenue

Main Geography (Y)

UNITED STATES

ThermoGenesis Revenue by Period

ThermoGenesis Revenue by Year

Date	Revenue	Change
2023-12-31	$9.45M	-9.90%
2022-12-31	$10.48M	12.79%
2021-12-31	$9.29M	-4.62%
2020-12-31	$9.74M	-25.32%
2019-12-31	$13.05M	34.89%
2018-12-31	$9.67M	100.00%
2017-12-31	-	-100.00%
2017-06-30	$14.53M	21.76%
2016-06-30	$11.93M	-25.64%
2015-06-30	$16.04M	0.34%
2014-06-30	$15.99M	-11.00%
2013-06-30	$17.96M	-5.57%
2012-06-30	$19.02M	-18.71%
2011-06-30	$23.40M	1.35%
2010-06-30	$23.09M	16.61%
2009-06-30	$19.80M	-9.78%
2008-06-30	$21.95M	31.01%
2007-06-30	$16.75M	39.04%
2006-06-30	$12.05M	18.38%
2005-06-30	$10.18M	-12.61%
2004-06-30	$11.65M	14.32%
2003-06-30	$10.19M	6.68%
2002-06-30	$9.55M	64.87%
2001-06-30	$5.79M	37.54%
2000-06-30	$4.21M	-17.43%
1999-06-30	$5.10M	13.33%
1998-06-30	$4.50M	-31.82%
1997-06-30	$6.60M	60.98%
1996-06-30	$4.10M	24.24%
1995-06-30	$3.30M	22.22%
1994-06-30	$2.70M	-

ThermoGenesis generated $9.45M in revenue during NA 2023, up -9.90% compared to the previous quarter, and up 97.65% compared to the same period a year ago.

ThermoGenesis Revenue by Quarter

Date	Revenue	Change
2024-03-31	$2.74M	13.76%
2023-12-31	$2.41M	9.66%
2023-09-30	$2.19M	-3.48%
2023-06-30	$2.27M	-11.63%
2023-03-31	$2.57M	-3.89%
2022-12-31	$2.68M	26.52%
2022-09-30	$2.12M	-30.17%
2022-06-30	$3.03M	13.74%
2022-03-31	$2.66M	10.13%
2021-12-31	$2.42M	-23.43%
2021-09-30	$3.16M	43.48%
2021-06-30	$2.20M	45.09%
2021-03-31	$1.52M	-22.09%
2020-12-31	$1.95M	-17.32%
2020-09-30	$2.35M	5.04%
2020-06-30	$2.24M	-29.94%
2020-03-31	$3.20M	85.83%
2019-12-31	$1.72M	-57.57%
2019-09-30	$4.06M	-5.74%
2019-06-30	$4.30M	45.34%
2019-03-31	$2.96M	10.19%
2018-12-31	$2.69M	-13.65%
2018-09-30	$3.11M	55.34%
2018-06-30	$2.00M	7.34%
2018-03-31	$1.87M	-36.58%
2017-12-31	$2.94M	-4.07%
2017-09-30	$3.07M	-12.34%
2017-06-30	$3.50M	7.66%
2017-03-31	$3.25M	-18.80%
2016-12-31	$4.00M	6.32%
2016-09-30	$3.77M	26.41%
2016-06-30	$2.98M	5.23%
2016-03-31	$2.83M	-14.03%
2015-12-31	$3.29M	16.68%
2015-09-30	$2.82M	-23.74%
2015-06-30	$3.70M	-8.41%
2015-03-31	$4.04M	-12.94%
2014-12-31	$4.64M	27.03%
2014-09-30	$3.65M	-4.74%
2014-06-30	$3.84M	-4.98%
2014-03-31	$4.04M	-9.62%
2013-12-31	$4.47M	22.61%
2013-09-30	$3.64M	-12.13%
2013-06-30	$4.15M	-15.23%
2013-03-31	$4.89M	1.87%
2012-12-31	$4.80M	16.50%
2012-09-30	$4.12M	-8.01%
2012-06-30	$4.48M	-8.70%
2012-03-31	$4.91M	2.79%
2011-12-31	$4.78M	-1.73%
2011-09-30	$4.86M	-9.65%
2011-06-30	$5.38M	4.12%
2011-03-31	$5.17M	-11.86%
2010-12-31	$5.86M	-16.25%
2010-09-30	$7.00M	-2.49%
2010-06-30	$7.18M	50.63%
2010-03-31	$4.76M	-20.00%
2009-12-31	$5.96M	14.67%
2009-09-30	$5.19M	29.08%
2009-06-30	$4.02M	-21.85%
2009-03-31	$5.15M	-15.96%
2008-12-31	$6.13M	36.07%
2008-09-30	$4.50M	-37.32%
2008-06-30	$7.18M	27.21%
2008-03-31	$5.65M	-

ThermoGenesis generated $2.74M in revenue during Q1 2024, up 13.76% compared to the previous quarter, and up 102.28% compared to the same period a year ago.

ThermoGenesis Revenue Breakdown

ThermoGenesis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Service	$1.82M	$2.04M	$1.66M	$2.56M	$1.83M
Device Revenue	$6.86M	$886.00K	$1.50M	-	-
Clinical Revenue	$135.00K	$157.00K	$199.00K	$216.00K	$237.00K
Exclusivity Fee	$781.00K	$1.05M	$1.33M	$1.62M	$96.00K

ThermoGenesis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Device Revenue (71.46%), Service (19.00%), Exclusivity Fee (8.13%), and Clinical Revenue (1.41%).

Quarterly Revenue by Product

Product/Service	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Jun 19	Mar 19	Sep 18	Jun 18	Mar 18
Other	$185.00K	$153.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	$424.00K	-	$1.86M	$2.34M	$1.75M	$2.01M	$2.06M	$2.22M	$2.47M	$2.17M	$2.52M	$2.10M	$2.27M	$2.22M	$1.43M	$749.00K	$716.00K	-	-
Device Revenue	$2.13M	$3.70M	$1.67M	$733.00K	$753.00K	$795.00K	$815.00K	$1.49M	$1.41M	-	-	-	-	-	-	-	-	-	-
Exclusivity Fee	-	-	$976.00K	$1.12M	$1.19M	$1.26M	$72.00K	$71.00K	$71.00K	$71.00K	$71.00K	-	-	-	-	-	-	-	-
Product and Service, Other	-	-	-	-	-	$164.00K	$176.00K	$189.00K	-	-	-	-	-	-	-	-	-	-	-
Clinical Revenue	-	-	-	-	-	-	-	-	$202.00K	$205.00K	$211.00K	$217.00K	$216.00K	$218.00K	$251.00K	$250.00K	$250.00K	$7.00K	$9.00K

ThermoGenesis's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Device Revenue (77.75%), Service (15.49%), and Other (6.76%).

ThermoGenesis Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 19
All Other Countries	$573.00K
UNITED STATES	$6.79M

ThermoGenesis's latest annual revenue breakdown by geography, as of Dec 19: UNITED STATES (92.21%), and All Other Countries (7.79%).

Quarterly Revenue by Country

Country	Mar 24
UNITED STATES	$2.06M
All Other Countries	$617.00K
SINGAPORE	$56.00K

ThermoGenesis's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (75.41%), All Other Countries (22.54%), and SINGAPORE (2.05%).

ThermoGenesis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RPID	Rapid Micro Biosystems	$22.52M	$7.60M
HSCS	Heart Test Laboratories	$18.60M	-
VVOS	Vivos Therapeutics	$13.80M	$3.86M
NUWE	Nuwellis	$8.86M	$2.37M
RSLS	ReShape Lifesciences	$8.68M	$2.29M
SINT	Sintx	$2.63M	$799.00K
NAOV	NanoVibronix	$2.28M	$376.00K
TIVC	Tivic Health Systems	$1.18M	$126.00K
BJDX	Bluejay Diagnostics	-	-
BBLG	Bone Biologics	-	-

THMO Revenue FAQ

What is ThermoGenesis’s yearly revenue?

ThermoGenesis's yearly revenue for 2023 was $9.44M, representing a decrease of -9.90% compared to 2022. The company's yearly revenue for 2022 was $10.48M, representing an increase of 12.79% compared to 2021. THMO's yearly revenue for 2021 was $9.29M, representing a decrease of -4.62% compared to 2020.

What is ThermoGenesis’s quarterly revenue?

ThermoGenesis's quarterly revenue for Q1 2024 was $2.74M, a 13.76% increase from the previous quarter (Q4 2023), and a 6.42% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.41M, a 9.66% increase from the previous quarter (Q3 2023), and a -10.09% decrease year-over-year (Q4 2022). THMO's quarterly revenue for Q3 2023 was $2.19M, a -3.48% decrease from the previous quarter (Q2 2023), and a 3.74% increase year-over-year (Q3 2022).

What is ThermoGenesis’s revenue growth rate?

ThermoGenesis's revenue growth rate for the last 3 years (2021-2023) was 1.62%, and for the last 5 years (2019-2023) was -27.61%.

What are ThermoGenesis’s revenue streams?

ThermoGenesis's revenue streams in c 23 are Service, Device Revenue, Clinical Revenue, and Exclusivity Fee. Service generated $1.82M in revenue, accounting 19.00% of the company's total revenue, down -10.45% year-over-year. Device Revenue generated $6.86M in revenue, accounting 71.46% of the company's total revenue, up 674.60% year-over-year. Clinical Revenue generated $135K in revenue, accounting 1.41% of the company's total revenue, down -14.01% year-over-year. Exclusivity Fee generated $781K in revenue, accounting 8.13% of the company's total revenue, down -25.41% year-over-year.

What is ThermoGenesis’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of ThermoGenesis was Device Revenue. This segment made a revenue of $6.86M, representing 71.46% of the company's total revenue.